APO Research
Talk to an analyst

APO RESEARCH · REPORT

Animal Stem Cell Therapy

Animal stem cell therapy is a usage of animal’s stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing the sample to concentrate the stem cells. Finally, the therapy includes transferring the stem cells into the injured site for treatment. Animal stem cell therapy increases the expectancy of life in animals with no side effects. It is available for the treatment of arthritis, degenerative joint disorders, tendon, and ligaments injuries in animals. Stem cell therapy is most often used to treat dogs, cats, and horses. But recent developments made it possible to use animal stem cell therapy in tiger, pig, etc. Present animal stem cell therapy is studied in treatments of the inflammatory bowel, kidney, liver, heart and immune-mediated diseases respectively.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Animal stem cell therapy is a usage of animal’s stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing the sample to concentrate the stem cells. Finally, the therapy includes transferring the stem cells into the injured site for treatment. Animal stem cell therapy increases the expectancy of life in animals with no side effects. It is available for the treatment of arthritis, degenerative joint disorders, tendon, and ligaments injuries in animals. Stem cell therapy is most often used to treat dogs, cats, and horses. But recent developments made it possible to use animal stem cell therapy in tiger, pig, etc. Present animal stem cell therapy is studied in treatments of the inflammatory bowel, kidney, liver, heart and immune-mediated diseases respectively.

Selected research

Market Analysis & Forecast

Global Animal Stem Cell Therapy Market Analysis and Forecast 2026-2032

22 December 2025191 pages

Choose your research edition.

Industry ResearchAnimal Stem Cell Therapy Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Animal Stem Cell Therapy Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Animal Stem Cell Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Animal Stem Cell Therapy Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Animal Stem Cell Therapy Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Animal stem cell therapy is a usage of animal’s stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing the sample to concentrate the stem cells. Finally, the therapy includes transferring the stem cells into the injured site for treatment. Animal stem cell therapy increases the expectancy of life in animals with no side effects. It is available for the treatment of arthritis, degenerative joint disorders, tendon, and ligaments injuries in animals. Stem cell therapy is most often used to treat dogs, cats, and horses. But recent developments made it possible to use animal stem cell therapy in tiger, pig, etc. Present animal stem cell therapy is studied in treatments of the inflammatory bowel, kidney, liver, heart and immune-mediated diseases respectively.

Market competition is intense. Medivet Biologics LLC, VETSTEM BIOPHARMA and J-ARM, etc. are the leaders of the industry, with about 52% market shares.

North America is the largest consumption region of animal stem cell therapy, with a consumption market share nearly 58%. Japan is the second largest supplier of animal stem cell therapy, enjoying production market share nearly 15%.

Read the full market overview

Report Includes

This report presents an overview of global market for Animal Stem Cell Therapy, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Animal Stem Cell Therapy, also provides the revenue of main regions and countries. Of the upcoming market potential for Animal Stem Cell Therapy, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Animal Stem Cell Therapy revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Animal Stem Cell Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Animal Stem Cell Therapy revenue, projected growth trends, production technology, application and end-user industry.

Animal Stem Cell Therapy Segment by Company

Medivet Biologics LLC

VETSTEM BIOPHARMA

J-ARM

U.S. Stem Cell, Inc

VetCell Therapeutics

Celavet Inc.

Magellan Stem Cells

Kintaro Cells Power

Animal Stem Care

Animal Cell Therapies

Cell Therapy Sciences

Animacel

Animal Stem Cell Therapy Segment by Type

Dogs Stem Cell Therapy

Horses Stem Cell Therapy

Others Animals

Animal Stem Cell Therapy Segment by Application

Veterinary Hospitals

Research Organizations

Animal Stem Cell Therapy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Stem Cell Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Animal Stem Cell Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Stem Cell Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Animal Stem Cell Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Animal Stem Cell Therapy company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Animal Stem Cell Therapy revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Animal Stem Cell Therapy Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Dogs Stem Cell Therapy Major Player Table 3. Horses Stem Cell Therapy Major Player Table 4. Others Animals Major Player Table 5. Global Animal Stem Cell Therapy Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Veterinary Hospitals Major Player Table 7. Research Organizations Major Player Table 8. Animal Stem Cell Therapy Industry Trends Table 9. Animal Stem Cell Therapy Industry Drivers Table 10. Animal Stem Cell Therapy Industry Opportunities and Challenges Table 11. Animal Stem Cell Therapy Industry Restraints Table 12. Global Animal Stem Cell Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Animal Stem Cell Therapy Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Animal Stem Cell Therapy Market Share by Region (2021-2026) Table 15. Global Animal Stem Cell Therapy Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Animal Stem Cell Therapy Market Share by Region (2027-2032) Table 17. Global Animal Stem Cell Therapy Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Animal Stem Cell Therapy Revenue Market Share by Players (2021-2026) Table 19. Global Animal Stem Cell Therapy Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Animal Stem Cell Therapy Key Players Headquarters & Area Served Table 21. Global Animal Stem Cell Therapy Players, Product Type & Application Table 22. Global Animal Stem Cell Therapy Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Animal Stem Cell Therapy by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Animal Stem Cell Therapy Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Animal Stem Cell Therapy Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Animal Stem Cell Therapy Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Animal Stem Cell Therapy Revenue Market Share by Type (2021-2026) Table 29. Global Animal Stem Cell Therapy Revenue Market Share by Type (2027-2032) Table 30. Global Animal Stem Cell Therapy Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Animal Stem Cell Therapy Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Animal Stem Cell Therapy Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Animal Stem Cell Therapy Revenue Market Share by Application (2021-2026) Table 34. Global Animal Stem Cell Therapy Revenue Market Share by Application (2027-2032) Table 35. Medivet Biologics LLC Company Information Table 36. Medivet Biologics LLC Business Overview Table 37. Medivet Biologics LLC Animal Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Medivet Biologics LLC Animal Stem Cell Therapy Product Portfolio Table 39. Medivet Biologics LLC Recent Development Table 40. VETSTEM BIOPHARMA Company Information Table 41. VETSTEM BIOPHARMA Business Overview Table 42. VETSTEM BIOPHARMA Animal Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. VETSTEM BIOPHARMA Animal Stem Cell Therapy Product Portfolio Table 44. VETSTEM BIOPHARMA Recent Development Table 45. J-ARM Company Information Table 46. J-ARM Business Overview Table 47. J-ARM Animal Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. J-ARM Animal Stem Cell Therapy Product Portfolio Table 49. J-ARM Recent Development Table 50. U.S. Stem Cell, Inc Company Information Table 51. U.S. Stem Cell, Inc Business Overview Table 52. U.S. Stem Cell, Inc Animal Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. U.S. Stem Cell, Inc Animal Stem Cell Therapy Product Portfolio Table 54. U.S. Stem Cell, Inc Recent Development Table 55. VetCell Therapeutics Company Information Table 56. VetCell Therapeutics Business Overview Table 57. VetCell Therapeutics Animal Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. VetCell Therapeutics Animal Stem Cell Therapy Product Portfolio Table 59. VetCell Therapeutics Recent Development Table 60. Celavet Inc. Company Information Table 61. Celavet Inc. Business Overview Table 62. Celavet Inc. Animal Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Celavet Inc. Animal Stem Cell Therapy Product Portfolio Table 64. Celavet Inc. Recent Development Table 65. Magellan Stem Cells Company Information Table 66. Magellan Stem Cells Business Overview Table 67. Magellan Stem Cells Animal Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Magellan Stem Cells Animal Stem Cell Therapy Product Portfolio Table 69. Magellan Stem Cells Recent Development Table 70. Kintaro Cells Power Company Information Table 71. Kintaro Cells Power Business Overview Table 72. Kintaro Cells Power Animal Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Kintaro Cells Power Animal Stem Cell Therapy Product Portfolio Table 74. Kintaro Cells Power Recent Development Table 75. Animal Stem Care Company Information Table 76. Animal Stem Care Business Overview Table 77. Animal Stem Care Animal Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Animal Stem Care Animal Stem Cell Therapy Product Portfolio Table 79. Animal Stem Care Recent Development Table 80. Animal Cell Therapies Company Information Table 81. Animal Cell Therapies Business Overview Table 82. Animal Cell Therapies Animal Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Animal Cell Therapies Animal Stem Cell Therapy Product Portfolio Table 84. Animal Cell Therapies Recent Development Table 85. Cell Therapy Sciences Company Information Table 86. Cell Therapy Sciences Business Overview Table 87. Cell Therapy Sciences Animal Stem Cell Therapy Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Cell Therapy Sciences Animal Stem Cell Therapy Product Portfolio Table 89. Cell Therapy Sciences Recent Development Table 90. Animacel Company Information Table 91. Animacel Business Overview Table 92. Animacel Animal Stem Cell Therapy Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Animacel Animal Stem Cell Therapy Product Portfolio Table 94. Animacel Recent Development Table 95. North America Animal Stem Cell Therapy Revenue by Type (2021-2026) & (US$ Million) Table 96. North America Animal Stem Cell Therapy Revenue by Type (2027-2032) & (US$ Million) Table 97. North America Animal Stem Cell Therapy Revenue by Application (2021-2026) & (US$ Million) Table 98. North America Animal Stem Cell Therapy Revenue by Application (2027-2032) & (US$ Million) Table 99. North America Animal Stem Cell Therapy Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. North America Animal Stem Cell Therapy Revenue by Country (2021-2026) & (US$ Million) Table 101. North America Animal Stem Cell Therapy Revenue by Country (US$ Million) & (2027-2032) Table 102. Europe Animal Stem Cell Therapy Revenue by Type (2021-2026) & (US$ Million) Table 103. Europe Animal Stem Cell Therapy Revenue by Type (2027-2032) & (US$ Million) Table 104. Europe Animal Stem Cell Therapy Revenue by Application (2021-2026) & (US$ Million) Table 105. Europe Animal Stem Cell Therapy Revenue by Application (2027-2032) & (US$ Million) Table 106. Europe Animal Stem Cell Therapy Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. Europe Animal Stem Cell Therapy Revenue by Country (2021-2026) & (US$ Million) Table 108. Europe Animal Stem Cell Therapy Revenue by Country (US$ Million) & (2027-2032) Table 109. China Animal Stem Cell Therapy Revenue by Type (2021-2026) & (US$ Million) Table 110. China Animal Stem Cell Therapy Revenue by Type (2027-2032) & (US$ Million) Table 111. China Animal Stem Cell Therapy Revenue by Application (2021-2026) & (US$ Million) Table 112. China Animal Stem Cell Therapy Revenue by Application (2027-2032) & (US$ Million) Table 113. Asia Animal Stem Cell Therapy Revenue by Type (2021-2026) & (US$ Million) Table 114. Asia Animal Stem Cell Therapy Revenue by Type (2027-2032) & (US$ Million) Table 115. Asia Animal Stem Cell Therapy Revenue by Application (2021-2026) & (US$ Million) Table 116. Asia Animal Stem Cell Therapy Revenue by Application (2027-2032) & (US$ Million) Table 117. Asia Animal Stem Cell Therapy Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Asia Animal Stem Cell Therapy Revenue by Region (US$ Million) & (2021-2026) Table 119. Asia Animal Stem Cell Therapy Revenue by Region (US$ Million) & (2027-2032) Table 120. SAMEA Animal Stem Cell Therapy Revenue by Type (2021-2026) & (US$ Million) Table 121. SAMEA Animal Stem Cell Therapy Revenue by Type (2027-2032) & (US$ Million) Table 122. SAMEA Animal Stem Cell Therapy Revenue by Application (2021-2026) & (US$ Million) Table 123. SAMEA Animal Stem Cell Therapy Revenue by Application (2027-2032) & (US$ Million) Table 124. SAMEA Animal Stem Cell Therapy Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. SAMEA Animal Stem Cell Therapy Revenue by Country (2021-2026) & (US$ Million) Table 126. SAMEA Animal Stem Cell Therapy Revenue by Country (US$ Million) & (2027-2032) Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Animal Stem Cell Therapy Image Figure 2. Global Animal Stem Cell Therapy Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Animal Stem Cell Therapy Market Size Share 2021 VS 2025 VS 2032 Figure 4. Dogs Stem Cell Therapy Image Figure 5. Horses Stem Cell Therapy Image Figure 6. Others Animals Image Figure 7. Global Animal Stem Cell Therapy Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Animal Stem Cell Therapy Market Size Share 2021 VS 2025 VS 2032 Figure 9. Veterinary Hospitals Image Figure 10. Research Organizations Image Figure 11. Global Animal Stem Cell Therapy Market Size (US$ Million) & (2021-2032) Figure 12. Global Animal Stem Cell Therapy Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Animal Stem Cell Therapy Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Animal Stem Cell Therapy Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Animal Stem Cell Therapy Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Animal Stem Cell Therapy Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Animal Stem Cell Therapy Revenue Market Share by Type (2021-2032) Figure 19. Global Animal Stem Cell Therapy Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Animal Stem Cell Therapy Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Animal Stem Cell Therapy Revenue Market Share by Application (2021-2032) Figure 22. North America Animal Stem Cell Therapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Animal Stem Cell Therapy Revenue Share by Type (2021-2032) Figure 24. North America Animal Stem Cell Therapy Revenue Share by Application (2021-2032) Figure 25. North America Animal Stem Cell Therapy Revenue Share by Country (2021-2032) Figure 26. United States Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Animal Stem Cell Therapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Animal Stem Cell Therapy Revenue Share by Type (2021-2032) Figure 31. Europe Animal Stem Cell Therapy Revenue Share by Application (2021-2032) Figure 32. Europe Animal Stem Cell Therapy Revenue Share by Country (2021-2032) Figure 33. Germany Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Animal Stem Cell Therapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Animal Stem Cell Therapy Revenue Share by Type (2021-2032) Figure 43. China Animal Stem Cell Therapy Revenue Share by Application (2021-2032) Figure 44. Asia Animal Stem Cell Therapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Animal Stem Cell Therapy Revenue Share by Type (2021-2032) Figure 46. Asia Animal Stem Cell Therapy Revenue Share by Application (2021-2032) Figure 47. Asia Animal Stem Cell Therapy Revenue Share by Region (2021-2032) Figure 48. Japan Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Animal Stem Cell Therapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Animal Stem Cell Therapy Revenue Share by Type (2021-2032) Figure 56. SAMEA Animal Stem Cell Therapy Revenue Share by Application (2021-2032) Figure 57. SAMEA Animal Stem Cell Therapy Revenue Share by Country (2021-2032) Figure 58. Brazil Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Animal Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Dogs Stem Cell Therapy
  • Horses Stem Cell Therapy
  • Others Animals
Applications
  • Veterinary Hospitals
  • Research Organizations
Companies covered
  • Medivet Biologics LLC
  • VETSTEM BIOPHARMA
  • J-ARM
  • U.S. Stem Cell, Inc
  • VetCell Therapeutics
  • Celavet Inc.
  • Magellan Stem Cells
  • Kintaro Cells Power
  • Animal Stem Care
  • Animal Cell Therapies
  • Cell Therapy Sciences
  • Animacel

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Animal Stem Cell Therapy Market by Type
  3. 1.2.1 Global Animal Stem Cell Therapy Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Dogs Stem Cell Therapy
  5. 1.2.3 Horses Stem Cell Therapy
  6. 1.2.4 Others Animals
  7. 1.3 Animal Stem Cell Therapy Market by Application
  8. 1.3.1 Global Animal Stem Cell Therapy Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Veterinary Hospitals
  10. 1.3.3 Research Organizations
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Animal Stem Cell Therapy Market Dynamics
  1. 2.1 Animal Stem Cell Therapy Industry Trends
  2. 2.2 Animal Stem Cell Therapy Industry Drivers
  3. 2.3 Animal Stem Cell Therapy Industry Opportunities and Challenges
  4. 2.4 Animal Stem Cell Therapy Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Animal Stem Cell Therapy Market Perspective (2021-2032)
  2. 3.2 Global Animal Stem Cell Therapy Growth Trends by Region
  3. 3.2.1 Global Animal Stem Cell Therapy Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Animal Stem Cell Therapy Market Size by Region (2021-2026)
  5. 3.2.3 Global Animal Stem Cell Therapy Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Animal Stem Cell Therapy Revenue by Players
  2. 4.1.1 Global Animal Stem Cell Therapy Revenue by Players (2021-2026)
  3. 4.1.2 Global Animal Stem Cell Therapy Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Animal Stem Cell Therapy Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Animal Stem Cell Therapy Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Animal Stem Cell Therapy Key Players Headquarters & Area Served
  7. 4.4 Global Animal Stem Cell Therapy Players, Product Type & Application
  8. 4.5 Global Animal Stem Cell Therapy Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Animal Stem Cell Therapy Market CR5 and HHI
  11. 4.6.3 2025 Animal Stem Cell Therapy Tier 1, Tier 2, and Tier 3
5 Animal Stem Cell Therapy Market Size by Type
  1. 5.1 Global Animal Stem Cell Therapy Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Animal Stem Cell Therapy Revenue by Type (2021-2032)
  3. 5.3 Global Animal Stem Cell Therapy Revenue Market Share by Type (2021-2032)
6 Animal Stem Cell Therapy Market Size by Application
  1. 6.1 Global Animal Stem Cell Therapy Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Animal Stem Cell Therapy Revenue by Application (2021-2032)
  3. 6.3 Global Animal Stem Cell Therapy Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Medivet Biologics LLC
  2. 7.1.1 Medivet Biologics LLC Company Information
  3. 7.1.2 Medivet Biologics LLC Business Overview
  4. 7.1.3 Medivet Biologics LLC Animal Stem Cell Therapy Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Medivet Biologics LLC Animal Stem Cell Therapy Product Portfolio
  6. 7.1.5 Medivet Biologics LLC Recent Developments
  7. 7.2 VETSTEM BIOPHARMA
  8. 7.2.1 VETSTEM BIOPHARMA Company Information
  9. 7.2.2 VETSTEM BIOPHARMA Business Overview
  10. 7.2.3 VETSTEM BIOPHARMA Animal Stem Cell Therapy Revenue and Gross Margin (2021-2026)
  11. 7.2.4 VETSTEM BIOPHARMA Animal Stem Cell Therapy Product Portfolio
  12. 7.2.5 VETSTEM BIOPHARMA Recent Developments
  13. 7.3 J-ARM
  14. 7.3.1 J-ARM Company Information
  15. 7.3.2 J-ARM Business Overview
  16. 7.3.3 J-ARM Animal Stem Cell Therapy Revenue and Gross Margin (2021-2026)
  17. 7.3.4 J-ARM Animal Stem Cell Therapy Product Portfolio
  18. 7.3.5 J-ARM Recent Developments
  19. 7.4 U.S. Stem Cell, Inc
  20. 7.4.1 U.S. Stem Cell, Inc Company Information
  21. 7.4.2 U.S. Stem Cell, Inc Business Overview
  22. 7.4.3 U.S. Stem Cell, Inc Animal Stem Cell Therapy Revenue and Gross Margin (2021-2026)
  23. 7.4.4 U.S. Stem Cell, Inc Animal Stem Cell Therapy Product Portfolio
  24. 7.4.5 U.S. Stem Cell, Inc Recent Developments
  25. 7.5 VetCell Therapeutics
  26. 7.5.1 VetCell Therapeutics Company Information
  27. 7.5.2 VetCell Therapeutics Business Overview
  28. 7.5.3 VetCell Therapeutics Animal Stem Cell Therapy Revenue and Gross Margin (2021-2026)
  29. 7.5.4 VetCell Therapeutics Animal Stem Cell Therapy Product Portfolio
  30. 7.5.5 VetCell Therapeutics Recent Developments
  31. 7.6 Celavet Inc.
  32. 7.6.1 Celavet Inc. Company Information
  33. 7.6.2 Celavet Inc. Business Overview
  34. 7.6.3 Celavet Inc. Animal Stem Cell Therapy Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Celavet Inc. Animal Stem Cell Therapy Product Portfolio
  36. 7.6.5 Celavet Inc. Recent Developments
  37. 7.7 Magellan Stem Cells
  38. 7.7.1 Magellan Stem Cells Company Information
  39. 7.7.2 Magellan Stem Cells Business Overview
  40. 7.7.3 Magellan Stem Cells Animal Stem Cell Therapy Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Magellan Stem Cells Animal Stem Cell Therapy Product Portfolio
  42. 7.7.5 Magellan Stem Cells Recent Developments
  43. 7.8 Kintaro Cells Power
  44. 7.8.1 Kintaro Cells Power Company Information
  45. 7.8.2 Kintaro Cells Power Business Overview
  46. 7.8.3 Kintaro Cells Power Animal Stem Cell Therapy Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Kintaro Cells Power Animal Stem Cell Therapy Product Portfolio
  48. 7.8.5 Kintaro Cells Power Recent Developments
  49. 7.9 Animal Stem Care
  50. 7.9.1 Animal Stem Care Company Information
  51. 7.9.2 Animal Stem Care Business Overview
  52. 7.9.3 Animal Stem Care Animal Stem Cell Therapy Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Animal Stem Care Animal Stem Cell Therapy Product Portfolio
  54. 7.9.5 Animal Stem Care Recent Developments
  55. 7.10 Animal Cell Therapies
  56. 7.10.1 Animal Cell Therapies Company Information
  57. 7.10.2 Animal Cell Therapies Business Overview
  58. 7.10.3 Animal Cell Therapies Animal Stem Cell Therapy Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Animal Cell Therapies Animal Stem Cell Therapy Product Portfolio
  60. 7.10.5 Animal Cell Therapies Recent Developments
  61. 7.11 Cell Therapy Sciences
  62. 7.11.1 Cell Therapy Sciences Company Information
  63. 7.11.2 Cell Therapy Sciences Business Overview
  64. 7.11.3 Cell Therapy Sciences Animal Stem Cell Therapy Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Cell Therapy Sciences Animal Stem Cell Therapy Product Portfolio
  66. 7.11.5 Cell Therapy Sciences Recent Developments
  67. 7.12 Animacel
  68. 7.12.1 Animacel Company Information
  69. 7.12.2 Animacel Business Overview
  70. 7.12.3 Animacel Animal Stem Cell Therapy Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Animacel Animal Stem Cell Therapy Product Portfolio
  72. 7.12.5 Animacel Recent Developments
8 North America
  1. 8.1 North America Animal Stem Cell Therapy Revenue (2021-2032)
  2. 8.2 North America Animal Stem Cell Therapy Revenue by Type (2021-2032)
  3. 8.2.1 North America Animal Stem Cell Therapy Revenue by Type (2021-2026)
  4. 8.2.2 North America Animal Stem Cell Therapy Revenue by Type (2027-2032)
  5. 8.3 North America Animal Stem Cell Therapy Revenue Share by Type (2021-2032)
  6. 8.4 North America Animal Stem Cell Therapy Revenue by Application (2021-2032)
  7. 8.4.1 North America Animal Stem Cell Therapy Revenue by Application (2021-2026)
  8. 8.4.2 North America Animal Stem Cell Therapy Revenue by Application (2027-2032)
  9. 8.5 North America Animal Stem Cell Therapy Revenue Share by Application (2021-2032)
  10. 8.6 North America Animal Stem Cell Therapy Revenue by Country
  11. 8.6.1 North America Animal Stem Cell Therapy Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Animal Stem Cell Therapy Revenue by Country (2021-2026)
  13. 8.6.3 North America Animal Stem Cell Therapy Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Animal Stem Cell Therapy Revenue (2021-2032)
  2. 9.2 Europe Animal Stem Cell Therapy Revenue by Type (2021-2032)
  3. 9.2.1 Europe Animal Stem Cell Therapy Revenue by Type (2021-2026)
  4. 9.2.2 Europe Animal Stem Cell Therapy Revenue by Type (2027-2032)
  5. 9.3 Europe Animal Stem Cell Therapy Revenue Share by Type (2021-2032)
  6. 9.4 Europe Animal Stem Cell Therapy Revenue by Application (2021-2032)
  7. 9.4.1 Europe Animal Stem Cell Therapy Revenue by Application (2021-2026)
  8. 9.4.2 Europe Animal Stem Cell Therapy Revenue by Application (2027-2032)
  9. 9.5 Europe Animal Stem Cell Therapy Revenue Share by Application (2021-2032)
  10. 9.6 Europe Animal Stem Cell Therapy Revenue by Country
  11. 9.6.1 Europe Animal Stem Cell Therapy Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Animal Stem Cell Therapy Revenue by Country (2021-2026)
  13. 9.6.3 Europe Animal Stem Cell Therapy Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Animal Stem Cell Therapy Revenue (2021-2032)
  2. 10.2 China Animal Stem Cell Therapy Revenue by Type (2021-2032)
  3. 10.2.1 China Animal Stem Cell Therapy Revenue by Type (2021-2026)
  4. 10.2.2 China Animal Stem Cell Therapy Revenue by Type (2027-2032)
  5. 10.3 China Animal Stem Cell Therapy Revenue Share by Type (2021-2032)
  6. 10.4 China Animal Stem Cell Therapy Revenue by Application (2021-2032)
  7. 10.4.1 China Animal Stem Cell Therapy Revenue by Application (2021-2026)
  8. 10.4.2 China Animal Stem Cell Therapy Revenue by Application (2027-2032)
  9. 10.5 China Animal Stem Cell Therapy Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Animal Stem Cell Therapy Revenue (2021-2032)
  2. 11.2 Asia Animal Stem Cell Therapy Revenue by Type (2021-2032)
  3. 11.2.1 Asia Animal Stem Cell Therapy Revenue by Type (2021-2026)
  4. 11.2.2 Asia Animal Stem Cell Therapy Revenue by Type (2027-2032)
  5. 11.3 Asia Animal Stem Cell Therapy Revenue Share by Type (2021-2032)
  6. 11.4 Asia Animal Stem Cell Therapy Revenue by Application (2021-2032)
  7. 11.4.1 Asia Animal Stem Cell Therapy Revenue by Application (2021-2026)
  8. 11.4.2 Asia Animal Stem Cell Therapy Revenue by Application (2027-2032)
  9. 11.5 Asia Animal Stem Cell Therapy Revenue Share by Application (2021-2032)
  10. 11.6 Asia Animal Stem Cell Therapy Revenue by Country
  11. 11.6.1 Asia Animal Stem Cell Therapy Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Animal Stem Cell Therapy Revenue by Country (2021-2026)
  13. 11.6.3 Asia Animal Stem Cell Therapy Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Animal Stem Cell Therapy Revenue (2021-2032)
  2. 12.2 SAMEA Animal Stem Cell Therapy Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Animal Stem Cell Therapy Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Animal Stem Cell Therapy Revenue by Type (2027-2032)
  5. 12.3 SAMEA Animal Stem Cell Therapy Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Animal Stem Cell Therapy Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Animal Stem Cell Therapy Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Animal Stem Cell Therapy Revenue by Application (2027-2032)
  9. 12.5 SAMEA Animal Stem Cell Therapy Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Animal Stem Cell Therapy Revenue by Country
  11. 12.6.1 SAMEA Animal Stem Cell Therapy Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Animal Stem Cell Therapy Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Animal Stem Cell Therapy Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst